INmune Bio
Price & Volume
Stats
See more52W Range | $1.38-$10.50 |
Market Cap | $40.1M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $50,000 |
Revenue Growth (YoY) | 257.1% |
Gross Profit (12 Mos) | $50,000 |
Diluted EPS | -$2.08 |
News
See moreYahoo Finance • 7 days ago
INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference
Yahoo Finance • 26 days ago
INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update
Yahoo Finance • 4 months ago
INmune Bio outlines CORDStrom BLA and MAA filings targeted for mid-2026 as CEO transition highlights strategic shift
Yahoo Finance • 4 months ago
INmune Bio August 2025 slides: three-platform strategy shows clinical progress
About
CEO | Mr. David J. Moss M.B.A. |
Address | 225 NE Mizner Blvd., Boca Raton, FL, United States, 33432 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 13 |
